Résultats de la recherche - 3 results
Interim analysis of COVID-19 vaccine effectiveness against hospitalisation and death using electronic health records in six European countries
mostly ≤50% between April 2022 and March 2023 in all age groups (with a few point estimates >50%). It waned 12 weeks after administration and dropped even lower after 24 weeks. In the most recent ...
Regulatory issues regarding manufacture and control of vaccine adjuvants. The EU situation.
at batch release Belgian Change Clinical clinical trial Clinical trials Combination Components Control developing Development distribution EU European future Group Guidelines health Hepatitis Hepatitis ...
Differences in Antigenic Structure of Inactivated Polio Vaccines Made From Sabin Live-Attenuated and Wild-Type Poliovirus Strains: Impact on Vaccine Potency Assays.
Publication Type: Peer reviewed scientific article Authors: Laura Crawt; Eleanor Atkinson; Alison Tedcastle; Elaine Pegg; sIPV Study Group; Philip Minor; Gillian Cooper; Peter Rigsby; Javier Martin; ...